Stocks
Single names, sectors, valuations and the trades behind the tape, explained in plain language.
Why Most Stocks Underperform and How to Own the Winners in a Power-Law Market
In today's markets, almost all wealth creation comes from a handful of outlier stocks. Powerlaw Corp explains why this power-law dynamic is
How Secondaries Let Investors Tap Pre-IPO Value Creation at Powerlaw Corp
High-growth companies are staying private longer, creating more value before IPOs. Secondaries provide a path for everyday investors to part
St. James's Place net inflows drop 29% as cautious clients hoard cash
St. James's Place, a major UK wealth adviser, saw first-half net inflows drop 29% to £2.7 billion. Clients are holding more cash amid market
Air France-KLM and Lufthansa set to bid for 44.9% stake in TAP Air Portugal
Portugal is moving ahead with the sale of a 44.9% stake in state-backed TAP Air Portugal. Air France-KLM and Lufthansa are due to submit bin
BASF lifts 2026 outlook as Hormuz disruptions tighten chemical supply
BASF raised its 2026 earnings outlook thanks to better pricing from shipping disruptions around the Strait of Hormuz. The improvement came e
Gerresheimer sells plastics units to Apax for €1.5 billion to cut debt
Gerresheimer, a German packaging firm, is selling two plastics units to Apax Funds for €1.5 billion including debt. The deal is meant to cut
Greatland gold output rises but costs climb faster, shares dip 1%
Greatland Resources' June quarter gold output rose to 79,100 ounces, but its all-in sustaining cost surged to AU$2,312 per ounce. The higher
Vault Minerals gold output dips but cash flow surges on strong prices
Vault Minerals' gold output slipped to 89,338 ounces in the June quarter, but strong prices helped it generate AU$219 million in underlying
Ford raises 2026 profit forecast again as trucks and cost cuts offset tariff drag
Ford boosted its 2026 profit outlook for the third time this year, now targeting $10-11 billion in EBIT. Strong sales of gas-powered trucks
UBS Says Boston Scientific's Stock Overlooks Upcoming Heart Device Pipeline
UBS says Boston Scientific's stock has fallen enough that the market is pricing in sales declines through 2029. But the bank sees high-singl
Seer shareholders sweeten buyout offer to $2.55 per share with contingent value right
Activist shareholders Bradley Radoff and Michael Torok have increased their buyout offer for Seer to $2.55 per share. The new non-binding bi
Diana Shipping Questions Genco's Valuation Shift Amid Proxy Fight
Diana Shipping claims Genco's fleet value dropped $50 million since June, per VesselsValue. Diana questions why Genco changed its valuation